Palladon (Hydromorphone Hydrochloride)

Hydromorphone hydrochloride is an opioid that acts on the central nervous system to relieve pain. It is used in several clinical situations:

• Acute postoperative pain: provides rapid analgesia after surgery.
• Cancer‑related pain: helps control persistent pain associated with malignant disease.
• Severe chronic non‑cancer pain: used when other opioids are insufficient.
• Palliative care: contributes to comfort in end‑of‑life settings.

• Hydromorphone binds with high affinity to the mu‑opioid receptors in the central nervous system, inhibiting the release of excitatory neurotransmitters and altering pain perception pathways. This receptor activation reduces neuronal excitability, leading to decreased transmission of pain signals and an overall analgesic effect.

Hydromorphone may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Constipation: reduced bowel motility.
• Drowsiness: increased sleepiness or fatigue.
• Dry mouth: reduced salivation.
• Sweating: excessive perspiration.
• Itching: mild skin pruritus.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing.
• Severe hypotension: marked drop in blood pressure.
• Cardiac arrhythmias: abnormal heart rhythms.
• Dependence or addiction: potential for misuse.
• Anaphylaxis: rare severe allergic reaction.
• adrenal insufficiency: rare endocrine disturbance.

When prescribing hydromorphone, clinicians should consider several safety measures:

• Assess renal function: dose may need adjustment in renal impairment.
• Monitor respiratory status: watch for signs of respiratory depression.
• Evaluate for substance abuse history: risk of dependence.
• Use caution in the elderly: increased sensitivity to opioid effects.
• Avoid concurrent CNS depressants: may potentiate sedation.
• Store below 25°C: keep in the original packaging, protect from moisture.

Hydromorphone can interact with a variety of medicines, requiring careful management.

Major Interactions (Avoid)

• Benzodiazepines: combined use increases risk of respiratory depression.
• Barbiturriers     ");

Moderate  """  """  "" """ " "" "" " " "" " " " "" " " " " "" " " " " "